4.5 Article

N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride: An immune-enhancing adjuvant for hepatitis E virus recombinant polypeptide vaccine in mice

Journal

HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume 13, Issue 8, Pages 1818-1822

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2017.1331191

Keywords

N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride; hepatitis E virus; vaccine; adjuvant; cell-mediated immunity; humoral immunity

Funding

  1. Traditional Chinese Medicine Science and Technology Planning Project of Zhejiang Province, China [2017ZB023]
  2. Public Technology Research and Social Development Project of Zhejiang Province, China [2014C33276]

Ask authors/readers for more resources

Adjuvants are essential for enhancing vaccine potency by improving the humoral and/or cell-mediated immune response to vaccine antigens. This study was performed to evaluate the immuno-enhancing characteristic of N-(2-hydroxy) propyl-3-trimethylammonium chitosan chloride (HTCC), the cationically modified chitosan, as an adjuvant for hepatitis E virus (HEV) recombinant polypeptide vaccine. Animal experiments showed that HTCC provides adjuvant activity when co-administered with HEV recombinant polypeptide vaccine by intramuscularly route. Vaccination using HTCC as an adjuvant was associated with increases of the serum HEV-specific IgG antibodies, splenocytes proliferation and the growths of CD4(+)CD8(-) T lymphocytes and IFN--secreting T lymphocytes in peripheral blood. These findings suggested that HTCC had strong immuno-enhancing effect. Our findings are the first to demonstrate that HTCC is safe and effective in inducing a good antibody response and stimulating Th1-biased immune responses for HEV recombinant polypeptide vaccine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available